Study: Cannabis an Effective Medicine in Early and Late Stage Dementia

dementiaA new study published in the Journal of Alzheimer’s Disease has found that cannabis is not only an effective medicine in the early stages of dementia, it’s also effective in its late stages.

“Previous reports have demonstrated that the combination of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) botanical extracts, which are the components of an already approved cannabis-based medicine, reduce the Alzheimer-like phenotype of AβPP/PS1 transgenic mice when chronically administered during the early symptomatic stage”, begins the study’s abstract. “Here, we provide evidence that such natural cannabinoids are still effective in reducing memory impairment in AβPP/PS1 mice at advanced stages of the disease”.

Read moreStudy: Cannabis an Effective Medicine in Early and Late Stage Dementia

Study: Cannabis Oil is a Safe and Effective Treatment Option for Alzheimer’s Disease

Alzheimer's DiseaseA study being published in the upcoming issue of the Journal of Alzheimer’s Disease, and e-published ahead of print by the National Institute of Health, has found that cannabis oil is a safe and effective treatment option for Alzheimer’s disease, which affects over 5 million U.S. citizens.

According to researchers, the objective of the study was; “To measure efficacy and safety of medical cannabis oil (MCO) containing THC as an add-on to pharmacotherapy, in relieving behavioral and psychological symptoms of dementia (BPSD).”

Read moreStudy: Cannabis Oil is a Safe and Effective Treatment Option for Alzheimer’s Disease

New Study: THC May Slow, Halt Progression of Alzheimer’s Disease

Extremely low doses of the cannabis compound delta-9-tetrahydrocannabinol (THC) may slow or even halt entirely the progressionBrain of Alzheimer’s disease, a new study from neuroscientists at the University of South Florida (USF) shows.

Findings from the research were reported online in the Journal of Alzheimer’s Disease.

For the study, researchers from the USF Health Byrd Alzheimer’s Institute showed that extremely low doses of THC reduced the production of amyloid beta (which is found in a soluble form in most aging brains), and prevented abnormal accumulation of this protein – a process considered to be one of the pathological hallmarks in Alzheimer’s disease. The THC was also found to selectively enhance mitochondrial function, which is needed to help supply energy, transmit signals, and maintain a healthy brain.

Read moreNew Study: THC May Slow, Halt Progression of Alzheimer’s Disease

New Study: THC May Treat Alzheimer’s Disease

A study published in this month’s issue of the Journal of Alzheimer’s Disease, and published online ahead of print by the U.S. National Institute of Health, has found strong evidence to suggest that THC (tetrahydrocannabinol) may provide a treatment option for Alzheimer’s disease.

“The purpose of this study was to investigate the potential therapeutic qualities of Δ9-tetrahydrocannabinol (THC) with respect to slowing or halting the hallmark characteristics of Alzheimer’s disease”, claims the study’s researchers.

Read moreNew Study: THC May Treat Alzheimer’s Disease